T. Zeller, C. Müller, U. Frank
Oct 1, 2002
Citations
0
Influential Citations
28
Citations
Quality indicators
Journal
The Journal of Endovascular Therapy
Abstract
Purpose: To evaluate gadodiamide as an alternative contrast agent for peripheral and renal angioplasty in patients with contraindications to iodinated contrast media. Methods: Seventeen patients (10 men; mean age 74 years, range 68–83) with contraindication to iodinated contrast media were given gadodiamide as the contrast agent during peripheral and renal intra-arterial digital subtraction angiography (DSA) and subsequent percutaneous interventions (balloon angioplasty, stent placement). Results: The mean volume of gadodiamide used was 136 ± 46 mL (range 60–200). No serious side effects were observed, especially no change in renal or thyroid function; no exanthema or other allergic reactions were noted. In patients without renal artery intervention, serum creatinine at discharge remained unchanged (2.57 ± 1.43 mg/dL to 2.40 ± 1.28 mg/dL, p=NS). In patients undergoing angioplasty/stenting of renal artery stenoses, serum creatinine decreased significantly from 3.53 ± 1.75 mg/dL to 2.36 ± 1.15 mg/dL (p<0.01). All but 1 intervention was successful. Using a simple scoring system, 2 judges blinded to the contrast agent graded the quality of the peripheral DSAs as “good,” whereas renal DSA images were only “sufficient.” Conclusions: For patients with contraindications to iodinated materials, gadodiamide may be a suitable alternative for renal or peripheral DSA followed by angioplasty.